3rd Upstream Seminar, Switzerland – November 29th and 30th, 2016
Solutions for modern upstream bioprocessing
You are invited!
After the success of the former upstream seminars, we are pleased to invite you to the third edition of this event. This year will include an extended scope from cell-line and media development to GMP production of large molecules and cell-based vaccines.
| November 29th and 30th, 2016 | 3rd Upstream Seminar Hotel Royal Geneva, Switzerland |
Register Now |
This 3rd Upstream seminar "Solutions for modern upstream bioprocessing" will gather industry experts and thought leaders in upstream processing from diverse companies specialized in the development and production of biopharmaceuticals and vaccines.
During this session, you will have the opportunity to:
- Network with peers in a friendly environment to gain insights into latest industry trends and innovations in upstream processing,
- Learn from industry speakers who can provide critical feedback with regards to upstream process development strategies,
- Visit our Aubonne cGMP facility to interact with users of single-use bioreactor at 2000 L scale.
Agenda Day 1
29 November 2016
Cell line and media development strategies for modern expression systems
| 12:00 – 1:45 pm | Finger food and reception |
| 1:45 – 2:00 pm | Welcome and introduction |
| Christian G Martin – Merck, Life Science | |
| 2:00 – 2:30 pm | Modern media development: how to deal with the process, yield and quality attributes? |
| Martin Jordan – Merck, Healthcare | |
| 2:30 – 3:00 pm | Novel approach to cell culture media optimization |
| Elena Krendeleva – Biocad | |
| 3:00 – 3:30 pm | Development of advanced cell culture media technologies |
| Aline Zimmer – Merck, Life Science | |
| 3:30 – 4:00 pm | Coffee break and poster session |
| 4:00 – 4:30 pm | Raw materials for cell culture processes: from manufacturer to customer |
| Luc Kupers – Genzyme, a Sanofi Company | |
| 4:30 – 5:00 pm | New strategies for virus risk mitigation |
| David Onions – Bioreliance, a part of Merck | |
| 7:00 pm | Dinner at Edelweiss restaurant |
Agenda Day 2
30 November 2016
Flexible and scalable solutions from process development to cGMP manufacturing
| 8:45 – 9:00 am | Introduction day 2 |
| 9:00 – 9:30 am | Fast-track lentiviral vector upstream process development |
| Landry Bertaux – Sanofi Pasteur | |
| 9:30 – 10:00 am | Single-use bioreactor and r-trypsin evaluation for veterinary vaccine production |
| Géraldine Popovic – Merial | |
| 10:00 – 10:30 am | Scaling strategy from bench to 2000 L single-use and 15000 L stainless steel bioreactors |
| Nicolas Fouque – Merck, Healthcare | |
| 10:30 – 10:45 am | Coffee break |
| 10:45 – 11:15 am | Intensified perfusion processes: small scale modelling and cell culture media development |
| Delia Lyons – Merck, Life Science | |
| 11:15 – 12:00 pm | Flexible facility needs and opportunities |
| Maik Jornitz – G-Con | |
| Flexible facilities for flexible operations: case studies | |
| Sébastien Ribault – Merck, Biodevelopment | |
| 12:00 – 12:15 pm | Panel discussion |
| 12:15 – 1:15 pm | Lunch |
| 1:15 pm | Departure to Merck Healthcare facility (Aubonne) |
| 2:00 – 4:00 pm | Merck Aubonne facility presentation Flocculation in the 2000 L bioreactor: a solution for high cell density clarification Hands-on session with Mobius® 200 L and 2000 L single-use bioreactors |
| 5:00 pm | Arrival at Geneva Royal Hotel |
Space is limited, register now!
Agenda subject to change. Attendance of the 3rd Upstream seminar ("Solutions for modern upstream bioprocessing") is limited and available to pharma/biopharma manufacturers and academics only. The offer does not extend to any company that provides products or services to the pharma/biopharma industries. Merck reserves the right to revoke or refuse participation at any time. Attendance is free, though registration is required. Lunch, dinner, and coffee breaks are provided courtesy of Merck. Travel costs and hotel accommodation are at the expense of the attendees.